iSpecimen Reports Third Quarter 2024 Results
iSpecimen Inc. (ISPC)
Company Research
Source: GlobeNewswire
LEXINGTON, Mass., Nov. 07, 2024 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, today reported its financial and operating results for the three and nine month periods ended September 30, 2024. "The third quarter was a period of continued strategic transformation for iSpecimen, primarily driven by several key initiatives," said Tracy Curley, CEO of iSpecimen. "First, we completed a 1-for-20 reverse stock split which helped the Company maintain its Nasdaq listing. Additionally, we secured a $1,000,000 loan facility with favorable terms, an agreement which included access to an additional $1,000,000 revolving credit line tied to a future $5,000,000 financing, which we successfully completed on October 31, 2024.” "I am particularly pleased with the progress and success of our Supplier Refresh program, whic
Show less
Read more
Impact Snapshot
Event Time:
ISPC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ISPC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ISPC alerts
High impacting iSpecimen Inc. news events
Weekly update
A roundup of the hottest topics
ISPC
News
- iSpecimen Will Serve as a Preferred Provider of Cancer Biospecimens [Yahoo! Finance]Yahoo! Finance
- iSpecimen Releases Cancer Biospecimen Offering; Orders Anticipated of Over $9,500,000 AnnuallyGlobeNewswire
- iSpecimen Inc. Announces Closing of $5 Million Public Offering of Common Stock and Pre-Funded WarrantsGlobeNewswire
- iSpecimen Inc. Announces Pricing of $5 Million Public Offering of Common Stock and Pre-Funded WarrantsGlobeNewswire
- iSpecimen files to sell 1.2M shares of common stock [Seeking Alpha]Seeking Alpha
ISPC
Sec Filings
- 12/30/24 - Form 8-K
- 12/20/24 - Form 8-K
- 12/13/24 - Form 3
- ISPC's page on the SEC website